Tony Chang, PhD, joined Merck Ventures as an analyst in 2016 and transitioned into an Associate with the New Businesses team in April 2017. Prior to this, he was a technology commercialization officer at the University of Western Cape in South Africa where he was responsible for the development of several industry research collaborations and licensing deals. Previously, Tony was a consultant in the strategy practice of EY in Johannesburg. Tony received his PhD in medical biochemistry from the University of Cape Town and his MBA from Rotterdam School of Management, Erasmus University. Tony is based in Amsterdam.